In accordance with the Ministry of Food and Drug Safety's 'Drug Approval Change Order' (Drug Policy Division-No. 348, effective date January 14, 2014), the efficacy, dosage, and precautions for use of Dymit XR extended-release tablets have been changed.
For further details, please refer to the ‘Product Introduction’ section and attached documents.
Daimit XR Tab.
Attachments are original documents and may be in Korean. English editions are labeled separately.
Unification adjustment for metformin hydrochloride single agent (oral-sustained release tablet) (draft).Metformin hydrochloride single agent (oral-extended release tablet) unification adjustment (draft)..hwp · 58 KBDownload ↓